Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Stock Symbol
-
TRML on Nasdaq
There are no Buy or Sell transactions made by Mary Kay Fenton since 4/22/2024
Holdings reported by Mary Kay Fenton for Tourmaline Bio, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
68.1K |
$1.16M |
$16.99 |
Jul 3, 2023 |
Direct |
|
|
| Stock Appreciation Right |
150K |
|
|
Feb 1, 2023 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
150K |
|
|
Feb 1, 2023 |
Direct |
Common Stock |
|
Transactions reported by Mary Kay Fenton for Tourmaline Bio, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.